Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026
Same author

HLA Class I Expression is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer.

Molecular cancer research : MCR·2026
Same author

Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly-Expressed, Combinatorial Therapeutic Target.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Subclonal Complete Loss of <i>CDKN1B</i> as a Common Genomic Alteration in Prostate Cancer: Associations with Race and Prostate Cancer Outcomes.

bioRxiv : the preprint server for biology·2026
Same author

Loss of Methylthioadenosine Phosphorylase (MTAP) Expression: A Potentially Useful Tool for Distinguishing Sarcomatoid Urothelial Carcinoma From Inflammatory Myofibroblastic Tumor.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Prostate cancer molecular subtypes in systematic versus MRI-targeted biopsy cores at active surveillance: association of PTEN and ERG status with extreme grade reclassification.

Histopathology·2025

相关实验视频

Updated: Jul 17, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K

在前列腺癌中基于数字病理学的人工智能算法:在"黑盒子"内部.

Claire M de la Calle1,2, Alexander S Baras3, Tamara L Lotan3,4,5

  • 1Department of Urology, University of Washington, Seattle, WA, USA.

BJU international
|February 16, 2026
PubMed
概括

数字病理学的人工智能 (AI) 正在彻底改变前列腺癌的诊断和分级. 与传统方法相比,人工智能算法提供了更高的准确性,减少了变化,并增强了预后信息.

关键词:
人工智能的人工智能是人工智能.病理学的病理学预测 预测 预测 预测预后 预后 预后前列腺癌是前列腺癌.整个幻灯片图像的图像.

更多相关视频

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.3K
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

1.2K

相关实验视频

Last Updated: Jul 17, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.3K
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

1.2K

科学领域:

  • 数字病理学和人工智能 (AI) 在瘤学中的应用.
  • 组织病理学和用于癌症研究的计算病理学.

背景情况:

  • 分析数字病理幻灯片的AI算法正在改变泌尿癌诊断和分级.
  • 这些系统提供了超越传统方法的预后,预测和分子亚型信息.

研究的目的:

  • 审查最近的前列腺癌基因病理学AI系统的进展.
  • 评估AI性能与病理学家进行诊断和分级.
  • 突出AI在预后预测和治疗反应中的作用.

主要方法:

  • 对前列腺癌组织病理学中人工智能的当前文献的综述.
  • 对人工智能算法与病理学家进行瘤诊断和分级的比较分析.
  • 对预后AI算法与患者结果 (转移,死亡) 的基准测试.

主要成果:

  • 人工智能算法在瘤诊断和分级方面表现与病理学家相当或优于病理学家.
  • 人工智能显著降低了观察者之间的变化,并提供量化瘤指标.
  • 新兴的人工智能能力包括预测治疗反应和分子变化.

结论:

  • 数字病理学中的人工智能在标准化前列腺癌评估方面具有重大潜力.
  • 人工智能可以指导临床管理并改善患者的治疗结果.
  • 人工智能在临床实践中的实施面临着需要考虑的优势和障碍.